Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04488263 · ClinicalTrials.gov registry record

Natural History Study of Children and Adults With Neuroendocrine Neoplasms (NEN)s

A clinical trial, sponsored by National Cancer Institute (NCI).

Terminated
Registry status
30
Enrollment target

NCT04488263: Clinical Trial study, sponsored by National Cancer Institute (NCI).

NCT04488263 is a clinical trial that was terminated before completion, run by National Cancer Institute (NCI). The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04488263 was terminated before completion, sponsored by National Cancer Institute (NCI).

TERMINATED
Registry status
30 participants
Enrollment target

Study Summary

Background: Neuroendocrine neoplasms (NENs) are rare tumors that originate in neuroendocrine cells. NENs can affect almost any part of the body. People with low-grade tumors can live many years. But high-grade tumors can be very aggressive. Researchers want to learn more about this type of cancer. This may help them design better treatments and supportive care studies. Objective: To gain a better understanding of neuroendocrine neoplasms. Eligibility: People starting at age 3 and older who have or are suspected of having NENs and are enrolled in protocol 19C0016, Natural History and Biospecimen Acquisition Study for Children and Adults with Rare Solid Tumors Design: Participants will be screened with questions about their medical history. This may be done over the telephone or in person. Participants medical records, test results, and imaging results will be reviewed. They may have scans and blood tests. They may sign a separate consent form for some of the tests. Participants will complete paper or electronic surveys. The surveys will ask about the effects of cancer on their wellbeing. Participants may give samples of their tumors from previous surgeries or biopsies. These samples will be used to study their tumor genes. Participants will get advice on how to manage their NENs. They will also get recommendations about potential treatment options. Participants home doctors will be contacted every 6 to 12 months. They will give medical data such as imaging and test results. Participants may have follow-up visits at NIH every 6 to 12 months. Participants will contact researchers if there are any changes in their tumor. Participants will be followed on this study for life.

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2020-11-24
Est. Completion 2023-01-11

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT04488263

The ClinicalTrials.gov registry entry for NCT04488263 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT04488263 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04488263 about?

NCT04488263 is a clinical study titled "Natural History Study of Children and Adults With Neuroendocrine Neoplasms (NEN)s". Background: Neuroendocrine neoplasms (NENs) are rare tumors that originate in neuroendocrine cells. NENs can affect almost any part of the body. People with low-grade tumors can live many years. But high-grade tumors can be very aggressive. Researchers want to learn more about this type of cancer. ...

What is the current status of trial NCT04488263?

This trial is currently terminated. The enrollment target is 30 participants. The study started on 2020-11-24. Estimated completion is 2023-01-11.

Who is sponsoring clinical trial NCT04488263?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.